Movember is back. Throughout the month of November, men are skipping their razors in favour of sporting a moustache to help raise money and awareness for men's health issues like mental health and suicide prevention, testicular cancer and prostate cancer.

Metformin does not delay disease progression in men with low risk prostate cancer on active surveillance and is associated with worse outcomes in men with obesity, new data show.

New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2, and PALB2.

The NHS is embarking on a trial that could cut prostate cancer diagnosis times from weeks to a single day. The initiative uses artificial intelligence to analyze MRI scans, potentially transforming care for men with the most commonly diagnosed cancer in England.

Stage 2 prostate cancer is considered localized, meaning the cancer is still confined entirely within the prostate gland and has not spread to nearby lymph nodes (node 0 or N0) or distant parts of the body (metastasis 0 or M0).

Prostate and skin cancers are among the most common cancers affecting men. In Advanced Prostate Cancer, lifelong treatment modalities are making a difference, challenges remain for patients with

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven effectiveness in extending survival.

Many things are evaluated when doctors are putting a treatment plan together for prostate cancer patients. A new study says one more factor should be considered—chronological age.

Amid his blood clot recovery, Roker was hospitalized again in December 2022 due to medical “complications.” He made his triumphant return to Today the following month. Additionally, Roker missed several episodes of Today in May 2023 to undergo knee replacement surgery.